News | Heart Failure | June 08, 2016

Bleeding Hearts Predict Future Heart Failure

MRI findings may allow doctors to identify and treat those at risk

heart failure, muscle bleeding, British Cardiovascular Conference, MRI

June 8, 2016 — The amount a heart ‘bleeds’ following a heart attack can predict the severity of future heart failure, according to research presented at the British Cardiovascular Conference in Manchester, England.

Bleeding, or bruising in the heart, affects over 40 percent of people who suffer from a heart attack. The researchers have now found that this injury is associated with a higher risk of developing heart failure in the months following a heart attack.

There are 188,000 hospital episodes attributed to heart attack in the United Kingdom each year — around one every three minutes. But although around 7 out of 10 people now survive a heart attack, many are left with heart failure.

The British Heart Foundation-funded study found that bleeding was linked to a 2.6 times greater risk of adverse remodeling, where the heart muscle changes shape, which is a precursor to heart failure. It is also linked to a six times greater risk of either death or heart failure following a heart attack.

The researchers also validated a test for use at the time of heart attack treatment to rule-in or rule-out heart muscle bleeding, and the likelihood of survival free of heart failure. This information would be useful to doctors to identify patients who are at risk of adverse outcome for more intensive treatment. The findings will pave the way to find new treatments to prevent bleeding following a heart attack and the subsequent onset of heart failure.

Magnetic resonance imaging (MRI), a non-invasive scan, can be used after a heart attack to monitor heart muscle bleeding, which happens in phases. The first phase is in the 12 hours following a heart attack, and the second takes place within two to three days. This provides a window of opportunity to introduce treatments to prevent the second phase of bleeding, which could reduce or prevent the later onset of heart failure.

Prof. Colin Berry, from the University of Glasgow, who led the study said,

“This research has provided us with a new understanding of heart muscle injury and how it develops. We can now focus our research on developing new treatments to reduce the level of this injury following a heart attack.

“The study has also presented a new way of identifying those at a higher risk of heart failure before the condition develops. This knowledge can be used to identify those most in need of interventions and monitoring earlier.”

For more information: www.bcs.com/conference

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init